CEREVEL THERAPEUTICS HOLDING (CERE) Stock Cash Flow
NASDAQ:CERE - Nasdaq - US15678U1280 - Common Stock - Currency: USD
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -460.46M | -432.84M | -351.50M | -225.30M | -152.10M | |||
| Depreciation Amortization | 5.85M | 5.63M | 4.90M | 2.70M | 400.00K | |||
| Change In Working Capital | 21.55M | 16.11M | 28.10M | 15.50M | 17.70M | |||
| Interest Paid | 8.62M | 8.60M | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 614.00K | N/A | N/A | N/A | |||
| Other non cash items | 66.02M | 68.80M | 25.40M | 28.50M | 16.20M | |||
| OPERATING CASH FLOW | -367.05M | -342.30M | -293.20M | -178.50M | -117.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.74M | -3.81M | -4.00M | -10.50M | -18.90M | |||
| Other Investing Activity | -14.15M | 77.53M | -384.90M | -425.20M | -18.90M | |||
| INVESTING CASH FLOW | -17.89M | 73.72M | -388.80M | -435.70M | -18.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 334.80M | 31.25M | N/A | |||
| Stock Issued/Repurchased | 520.41M | 517.50M | 251.30M | 392.70M | N/A | |||
| Other Financing Activity | 31.25M | 31.11M | 37.10M | 30.90M | 440.80M | |||
| FINANCING CASH FLOW | 551.65M | 548.62M | 623.20M | 423.60M | 440.80M | |||
| CHANGE IN CASH | 166.71M | 280.04M | -58.80M | -190.60M | 304.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -367.05M | -342.30M | -293.20M | -178.50M | -117.80M | |||
| Capital Expenditure | -3.74M | -3.81M | -4.00M | -10.50M | -18.90M | |||
| FREE CASH FLOW | -370.79M | -346.11M | -297.20M | -189.00M | -136.70M | |||
All data in USD